Advertisement

Topics

Dr. Reddy's Laboratories Inc Company Profile

10:15 EDT 23rd June 2018 | BioPortfolio

Since its inception in 1984, Dr. Reddy's has chosen to walk the path of discovery and innovation in health sciences. Ours has been a quest to sustain and improve the quality of life, and we have had nearly two decades of creating safe pharmaceutical solutions with the ultimate purpose of making the world a healthier place. Our competencies cover the entire pharmaceutical value chain – API and Intermediates, Finished Dosages (Branded and Generic) and NCE Research.Our research centre uses cutting-edge technology and has discovered breakthrough pharmaceutical solutions in select therapeutic areas. In a short span of operations, we have filed for more than 75 patents. We are the first Indian company to out-license an NCE molecule for clinical trials. To strengthen our research arm, we have set up a research subsidiary, Reddy US Therapeutics Inc., in Atlanta, USA.

Location

200 Somerset Corporate BlvdBldg 2, 7th Floor
Bridge Water
New Jersey
08807
United States of America

Contact

Phone: 1-908-203-4900
Fax: 1-908-203-4914
Email: bkoprowski@drreddys.com


News Articles [319 Associated News Articles listed on BioPortfolio]

Dr. Reddy's Launches Levocetirizine Dihydrochloride Tablets In U.S. Market

NewsDr. Reddy’s Laboratories has launched an over-the-counter therapeutic equivalent generic version of Xyzal Allergy 24HR Tablets in the United States market.

FDA Approves First Generic Version Of Suboxone

NewsDr. Reddy's Laboratories announces final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. market.

Dr Reddy's receives FDA 483 at Indian API plant

The US FDA has issued a Form 483 with four observations to an API facility in Hyderabad, India run by Dr Reddyâs Laboratories.

Dr. Reddy’s Laboratories defends its right to launch Buprenorphine and Naloxone Sublingual Film in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that following the launch of its generic Bupr...

BRIEF—Dr Reddy’s files NDA for its migraine candidate

India’s Dr Reddy’s Laboratories has announced the filing of New Drug Application (NDA) for its migraine…

Court fines Dr Reddy’s for improperly packaging products

On 18 December 2017, the District of New Jersey filed a complaint against Dr. Reddy’s Laboratories for failing to comply with the Poison Prevention Packaging Act (PPPA) and the Consumer Product Safe...

Dr. Reddy’s Laboratories Announces FDA Final Approval and Launch of Buprenorphine and Naloxone Sublingual Film

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has received final approval from the U...

US court issues a restraint order against Dr Reddy’s new drug

Indian pharmaceutical company Dr Reddy’s Laboratories has announced that the US District Court in New Jersey has issued a temporary restraining...Read More... The post US court issues a restraint o...

PubMed Articles [175 Associated PubMed Articles listed on BioPortfolio]

Repeatability and variability of total T4 measurements at three German veterinary laboratories.

To evaluate the reproducibility of serum testing for total thyroxine (T4) in three German laboratories.

Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.

Increasingly used for clinical purposes, genome and exome sequencing can generate clinically relevant information that is not directly related to the reason for testing (incidental or secondary findin...

Cell-Free DNA Analysis in Maternal Blood: Differences in Estimates between Laboratories with Different Methodologies Using a Propensity Score Approach.

To evaluate the failure rate and performance of cell-free DNA (cfDNA) testing, mainly in terms of detection rates for trisomy 21, performed by 2 laboratories using different analytical methods.

The American Society for Clinical Pathology's 2016-2017 Vacancy Survey of Medical Laboratories in the United States.

To determine the extent and distribution of workforce shortages within the nation's medical laboratories.

Mapping of the US Domestic Influenza Virologic Surveillance Landscape.

Influenza virologic surveillance is critical each season for tracking influenza circulation, following trends in antiviral drug resistance, detecting novel influenza infections in humans, and selectin...

Clinical Trials [271 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition

The purpose of this bioequivalence study is to compare a test Glimepiride 1 mg tablets of Dr.Reddy's Laboratories Limited versus reference Amaryl 1 mg tablets of Aventis Pharmaceuticals In...

Companies [958 Associated Companies listed on BioPortfolio]

Reddy US Therapeutics, Inc

Reddy US Therapeutics, Inc., part of Dr. Reddy's Discovery Research, was established in November 1999. Our company is located in the wooded suburbs of Atlanta. We currently occupy over 25000 sq. ft. o...

Dr. Reddy’s Laboratories

Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company. We fulfill our purpose of providing affordable and innovative medicine...

Dr. Reddy’s Laboratories Ltd.

Unaudited Consolidated Income Statement

Dr. Reddy's Laboratories

Established in 1984, Dr. Reddy’s Laboratories (NYSE:RDY) is an emerging global pharmaceutical company. We fulfill our purpose of providing affordable and innovative medicines...

Dr. Reddy's Laboratories Ltd.

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Thro...

More Information about "Dr. Reddy's Laboratories Inc" on BioPortfolio

We have published hundreds of Dr. Reddy's Laboratories Inc news stories on BioPortfolio along with dozens of Dr. Reddy's Laboratories Inc Clinical Trials and PubMed Articles about Dr. Reddy's Laboratories Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dr. Reddy's Laboratories Inc Companies in our database. You can also find out about relevant Dr. Reddy's Laboratories Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record